103127-53-3

Basic information

• Product Name: TERT-BUTYL (1-BENZYL-2-OXOETHYL)CARBAMATE
• Synonyms: TERT-BUTYL (1-BENZYL-2-OXOETHYL)CARBAMATE;tert-butyl 1-oxo-3-phenylpropan-2-ylcarbaMate(raceMic);tert-butyl 1-oxo-3-phenylpropan-2-ylcarbamate
• CAS NO: 103127-53-3
• Molecular Formula: C₁₄H₁₉NO₃
• Molecular Weight: 249.308
• Mol File: 103127-53-3.mol

Chemical Properties

• Melting Point: 68-70°C
• Boiling Point: 367°Cat760mmHg
• Flash Point: 175.8°C
• Appearance: /
• Density: 1.077g/cm³
• Storage Temp.: 2-8°C
• CAS DataBase Reference: TERT-BUTYL (1-BENZYL-2-OXOETHYL)CARBAMATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL (1-BENZYL-2-OXOETHYL)CARBAMATE(103127-53-3)
• EPA Substance Registry System: TERT-BUTYL (1-BENZYL-2-OXOETHYL)CARBAMATE(103127-53-3)

Safety Data

• Hazardous Substances Data: 103127-53-3(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
TERT-BUTYL (1-BENZYL-2-OXOETHYL)CARBAMATE is used as a protecting group for amines during chemical reactions, allowing chemists to control the reaction process and selectively modify the desired functional groups. Its easy addition and removal under specific conditions make it a valuable tool in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, TERT-BUTYL (1-BENZYL-2-OXOETHYL)CARBAMATE is utilized for the synthesis of complex molecules. Its role as a protecting group aids in the controlled formation of pharmaceutical compounds, contributing to the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
TERT-BUTYL (1-BENZYL-2-OXOETHYL)CARBAMATE also finds application in the agrochemical industry, where it serves as a building block for the production of various compounds. Its use in the synthesis of agrochemicals helps in the development of effective pesticides, herbicides, and other agricultural chemicals.
Safety Precautions:
It is crucial to handle and use TERT-BUTYL (1-BENZYL-2-OXOETHYL)CARBAMATE with proper safety measures, as it can pose hazards if not managed correctly. Adhering to safety protocols ensures the protection of both the environment and the individuals involved in its production and application.

Upstream product

• 72155-45-4 Boc-L-phenylalaninal 
• 79-37-8 oxalyl dichloride 
• 145149-48-0 tert-butyl 1-hydroxy-3-phenylpropan-2-ylcarbamate 
• 77-92-9 citric acid 
• 1795-98-8 rac-phenylalaninol 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1224936-68-8 N-(tert-butoxycarbonyl)-phenylalanylimidazole 
• 4530-18-1 2-(tert-butoxycarbonylamino)-3-phenylpropionic acid 
• 51987-73-6 (S)-2-tert-butoxycarbonylamino-3-phenyl-propionic acid methyl ester 
• 63-91-2 L-phenylalanine 
• 7524-50-7 methyl (2S)-2-amino-3-phenylpropanoate hydrochloride 

Downstream Products

• 119906-55-7 ((Z)-1-Benzyl-5-trimethylsilanyl-pent-2-en-4-ynyl)-carbamic acid tert-butyl ester 
• 119906-54-6 ((E)-1-Benzyl-5-trimethylsilanyl-pent-2-en-4-ynyl)-carbamic acid tert-butyl ester 
• 193466-57-8 [1-Benzyl-2-(2,5-dihydroxy-phenyl)-ethyl]-carbamic acid tert-butyl ester 
• 403712-74-3 N¹,N¹-dimethyl-2-(N-tert-butoxycarbonyl)-3-phenyl-propane-1,2-diamine 

Relevant articles and documents

Fluorinated Olefinic Lactams: The Case of Amino Acids - Preparation and Mechanistic Studies

Herein, we report the synthesis of analogues of amino acids with a monofluorovinyl moiety. Interestingly, we have found that cyclization of the obtained products proceeds easily in all cases. The cyclization process has not previously been observed at this reaction stage, and such fluorinated lactams derived from phenylalanine, valine, alanine have not been described before.

METHODS OF TREATING LIVER FIBROSIS USING CALPAIN INHIBITORS

Disclosed herein are methods of treating liver fibrosis by administering calpain inhibitors to subjects in need thereof.

CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF

Small molecule calpain modulator compounds, including their pharmaceutically acceptable salts, can be included in pharmaceutical compositions. The compounds can be useful in inhibiting calpain, or competitive binding with calpastatin, by contacting them with CAPN1, CAPN2, and/or CAPN9 enzymes residing inside a subject. The compounds and composition can also be administered to a subject in order to treat a fibrotic disease or a secondary disease state or condition of a fibrotic disease.

Membrane-active antimicrobial poly(amino-modified alkyl) β-cyclodextrins synthesized: Via click reactions

The emergence of drug-resistant bacteria has led to the high demand for new antibiotics. In this report, we investigated membrane-active antimicrobial β-cyclodextrins. These contain seven amino-modified alkyl groups on a molecule, which act as functional

A rapid and efficient one-pot method for the reduction of N-protected α-amino acids to chiral α-amino aldehydes using CDI/DIBAL-H

N-Protected amino acids can be easily converted into chiral α-amino aldehydes in a one-pot reaction by activation with CDI followed by reduction with DIBAL-H. This method delivers Boc-, Cbz- and Fmoc-protected amino aldehydes from proteinogenic amino acids in very good isolated yields and complete stereointegrity.

Synthesis of proline analogues as potent and selective cathepsin S inhibitors

Cathepsin S is a potential target of autoimmune disease. A series of proline derived compounds were synthesized and evaluated as cathepsin S inhibitors. We discovered potent cathepsin S inhibitors through structure-activity relationship studies of proline analogues. In particular, compound 19-(S) showed promising in vitro/vivo pharmacological activities and properties as a selective cathepsin S inhibitor.

Synthesis and cytotoxicity evaluation of diastereoisomers and N-terminal analogues of tubulysin-U

Tubulysins are potent anti-mitotic natural compounds and a scalable and efficient synthetic route for generation of its analogues has been developed and extended to the synthesis of diastereoisomers and N-terminal analogues of tubulysin-U. Structure-activ

HETEROCYCLIC AMIDE COMPOUNDS AND PHARMACEUTICAL USE OF THE SAME

Heterocyclic amide compounds of the formula (I) STR1 wherein each symbol is as defined in the specification, pharmacologically acceptable salts thereof, pharmaceutical compositions thereof and pharmaceutical use thereof. The heterocyclic amide compounds and pharmacologically acceptable salts thereof of the present invention have superior inhibitory activity against chymase groups in mammals inclusive of human, and can be administered orally or parenterally. Therefore, they are useful as chymase inhibitors and can be effective for the prophylaxis and treatment of various diseases caused by chymase, such as those caused by angiotensin II.

Synthesis and Stereoselective Reactions of 2-(Pyrrol-1-yl)alkanals and 2-(pyrrol-1-yl)alkan-1-ones

2-(2,5-Dimethylpyrrol-1-yl)alkanals, 2-(pyrrol-1-yl)alkanals, and 2-(2,5-dimethylpyrrol-1-yl)alkan-1-ones were prepared.The reactions of these compounds with Grignard and hydride reagents proceeded stereoselectively to give the corresponding 2-(pyrrol-1-yl)alcohols, which were converted into 2-aminoalcohols, such as norephedrine and ephedrine, by cleavage of the pyrrole ring.